Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
In vivo testing of nanotherapeutics for osteosarcoma treatment: Translational challenges and solutions
As a glucagon-like peptide-1 (GLP-1) receptor agonist, it functions by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying, which collectively contribute to improved glycemic control and reduced appetite
Practical considerations including medication cost, insurance coverage, side effect tolerance, and patient preferences play important roles in treatment duration decisions
Stops mutations Stops molecules inert, preventing their destructive effects Vital for both phase I & phase II liver detoxification Induces normal p53(tumor suppressor) activity by redox modulation, which induces apoptosis in tumor cells Detoxification is another major function
